NEW YORK, NY / ACCESSWIRE / February 28, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Sasol Limited (NYSE:SSL)

Investors Affected : March 10, 2015 – January 13, 2020

A class action has commenced on behalf of certain shareholders in Sasol Limited. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Sasol had conducted insufficient due diligence into, and failed to account for multiple issues with, the Lake Charles Chemicals Project ("LCCP"), as well as the true cost of the project; (ii) construction and operation of the LCCP was consequently plagued by control weaknesses, delays, rising costs, and technical issues; (iii) these issues were exacerbated by Sasol's top-level management, who engaged in improper and unethical behavior with respect to financial reporting for the LCCP and the project's oversight; (iv) all the foregoing was reasonably likely to render the LCCP significantly more expensive than disclosed and negatively impact the Company's financial results; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/sasol-limited-loss-submission-form/?id=5541&from=1

Geron Corporation (NASDAQ:GERN)

Investors Affected : March 19, 2018 – September 26, 2018

A class action has commenced on behalf of certain shareholders in Geron Corporation. The filed complaint alleges that defendants misled investors regarding a drug called imetelstat, which was intended to treat certain cancers that occur in bone marrow. Specifically, defendants misled investors about the results of a clinical drug study of imetelstat called IMbark. That study was designed to ascertain whether imetelstat helped patients with a cancer called myelofibrosis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/geron-corporation-et-al-loss-submission-form/?id=5541&from=1

HP Inc. (NYSE:HPQ)

Investors Affected : February 23, 2017 – October 3, 2019

A class action has commenced on behalf of certain shareholders in HP Inc. According to the filed complaint, defendants knew that HP's "four-box" model for measuring its supplies business was severely deficient and not a strong predictor of supplies demand and outcomes because HP lacked telemetry data from its commercial printers and had to use unreliable and stagnant market share data to develop assumptions for the four-box model. The complaint further alleges that defendants knew the lack of telemetry data for commercial printing was a critical shortcoming of the four-box model because HP possessed telemetry data on its personal printing side and knew it was a necessary element for an accurate understanding of the supplies channel. As a result, the supplies inventory in the Company's channel exceeded demand by at least $100 million and HP's supplies revenue growth was grossly inflated.

Shareholders may find more information at https://securitiesclasslaw.com/securities/hp-inc-loss-submission-form/?id=5541&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 578347

NEW YORK, NY / ACCESSWIRE / February 28, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Opera Limited (NASDAQ:OPRA)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/opera-limited-loss-submission-form?prid=5540&wire=1
Lead Plaintiff Deadline: March 24, 2020
Class Period: (a) Opera American depositary shares pursuant and/or traceable to the Company's initial public offering commenced on or about July 27, 2018 and/or (b) Opera securities between July 27, 2018 and January 15, 2020,

Allegations against OPRA include that: (i) Opera's sustainable growth and market opportunity for its browser applications was significantly overstated; (ii) Defendants' funded, owned, or otherwise controlled loan services applications and/or businesses relied on predatory lending practices; (iii) all the foregoing, once revealed, were reasonably likely to have a material negative impact on Opera's financial prospects, especially with respect to its lending applications' continued availability on the Google Play Store; and (iv) as a result, the Offering Documents and Defendants' statements were materially false and/or misleading and failed to state information required to be stated therein.

Beyond Meat, Inc. (NASDAQ:BYND)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/beyond-meat-inc-loss-submission-form?prid=5540&wire=1
Lead Plaintiff Deadline: March 30, 2020
Class Period: May 2, 2019 to January 27, 2020

Allegations against BYND include that: (i) Beyond Meat's termination of its supply agreement with Don Lee constituted a breach of that agreement, thus exposing the Company to foreseeable legal liability and reputational harm; (ii) Beyond Meat and certain of its employees had doctored and omitted material information from a food safety consultant's report, which the Company represented as accurate to Don Lee; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Tupperware Brands Corporation (NYSE:TUP)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/tupperware-brands-corporation-loss-submission-form?prid=5540&wire=1
Lead Plaintiff Deadline: April 27, 2020
Class Period: January 30, 2019 to February 24, 2020

Allegations against TUP include that: (1) Tupperware lacked effective internal controls; (2) as a result, Tupperware would need to investigate the accounting and liabilities of one of its brands, Fuller Mexico; (3) consequently, Tupperware would be unable to timely file its annual report on Form 10-K for its fiscal year 2019; (4) Tupperware did not properly account for its accounts payable and accrued liabilities at Fuller Mexico; (5) Tupperware provided overvalued earnings per share guidance; (6) Tupperware would need relief from its $650 million Credit Agreement; and (7) as a result, defendants' public statements were materially false and/or misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 578346

MIAMI, FL / ACCESSWIRE / February 28, 2020 / Kisses from Italy Inc. (OTCQB:KITL) restaurant group and franchisor recently attended the Global Franchise show in Mumbai India, an event hosted by ExpanGlobal, a leading international market entry and expansion company headquartered in India. Michele Di Turi the President, Co-CEO and Co-Founder of Kisses from Italy, who attended the Global Franchise Show, stated that "Being at an event like this, that brings so many people together, is an important way to expand your brand exposure. There is nothing like making a face-to-face connection with potential business partners and franchisees." The event was held at the Sahara Star Hotel, a beautiful 5-star property near Mumbai's domestic airport. Di Turi added that "the ExpanGlobal team were very gracious hosts and we look forward to returning to India and working with ExpanGlobal in strengthening and promoting our brand in the national territory of India."

Kisses from Italy recently announced a partnership with ExpanGlobal. The companies have joined forces in order to drive growth for Kisses from Italy's overseas expansion, beginning with India.

From left to right: Mrinal Srivastava (Founder and President of Global Expansion for ExpanGlobal); Michele Di Turi (President, Co-CEO and Co-Founder of Kisses from Italy); Raghav Khattar (Founder and President of Marketing and Investor Relations)

Michele Di Turi (President, Co-CEO and Co-Founder of Kisses from Italy) pictured in the center, discussing the Kisses from Italy franchise brand and system with potential franchisees in Mumbai India.

About KISSES FROM ITALY Inc.

KISSES FROM ITALY is a U.S. based restaurant chain focused on fast-casual dining with traditional Italian Panini, homemade lasagna, salads, panzerotti di Bari, Italian coffee, dessert and breakfast offerings. The company currently operates four corporate owned stores. It successfully commenced operations in May 2015 with the opening of its flagship location in Ft. Lauderdale at 3146 NE 9th St. This was followed by three additional sites across the greater Ft. Lauderdale/Pompano Beach area. The Company recently opened its inaugural European location in Ceglie del Campo, Bari, Italy in October of 2019. In September of 2019, Kisses from Italy Inc. was given the approval by FINRA to trade its common stock and was approved for up-listing by the OTC Markets Group to the OTCQB in mid-October 2019 under the ticker symbol KITL.

For more information, please visit www.kissesfromitaly.com

Safe Harbor Statement

This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, Kisses from Italy Inc. may not be able to sustain growth or achieve profitability based upon many factors including, but not limited to, general stock market conditions. Reference is hereby made to cautionary statements set forth in the company's most recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of our existing and new service lines, noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where we will be providing services, the impact of which cannot be predicted at this time.

Contact Information:

Kisses from Italy Inc.
305-423-7129
info@kissesfromitaly.com

SOURCE: Kisses from Italy Inc.

ReleaseID: 578340

RESEARCH TRIANGLE PARK, N.C. / ACCESSWIRE / February 28, 2020 / Charles & Colvard, Ltd. (NASDAQ:CTHR), the original and leading worldwide source of created moissanite, announced that Suzanne Miglucci, President and CEO, and Clint J. Pete, Chief Financial Officer, will present at the third annual LD Micro Virtual Conference on Wednesday, March 4, 2020 at 12:20 p.m. ET.

A link to the live and archived webcast of the presentation may be accessed in the Investor Relations section of the Company's website: https://ir.charlesandcolvard.com/events.

About Charles & Colvard, Ltd.

Charles & Colvard, Ltd. (Nasdaq: CTHR) believes luxury can be beautiful and conscientious. As an e-commerce driven business, the Company brings revolutionary gemstones and jewelry to market through the use of innovative technology and direct-to-consumer engagement. Charles & Colvard is the original pioneer of lab-created moissanite, a rare gemstone formed from silicon carbide. Consumers seek Charles & Colvard fashion, bridal and fine jewelry because of its exceptional quality, incredible value and shared beliefs in environmental and social responsibility. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle. For more information, please visit https://www.charlesandcolvard.com/.

Contacts:
Clint J. Pete
Chief Financial Officer
919-468-0399
cpete@charlesandcolvard.com

Jenny Kobin
Investor Relations
800-695-0650
Jenny.Kobin@IRAdvisory.com

SOURCE: Charles & Colvard, Ltd.

ReleaseID: 578339

Transforms Aptevo into a ‘Pure Play' Biotechnology Company Focused on the Development of Proprietary ADAPTIR™ Bispecific Antibody Therapeutics

Strengthens Aptevo's Financial Position; Eliminates MidCap Debt Obligation; Provides Immediate Non-Dilutive Capital Extending Aptevo's Current Cash Runway

Recent Advances in Bispecific Programs Show Compelling Proof-of-Concept Clinical Data; Bispecifics Offer Key Advantages Over Other Cellular Therapies

Aptevo's Lead Bispecific Candidate APVO436 Recently Selected for Inclusion in Groundbreaking Beat AML® Master Clinical Trial

SEATTLE, WA / ACCESSWIRE / February 28, 2020 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, announced today that it has completed the sale of its marketed recombinant factor IX therapeutic, IXINITY® [Coagulation Factor IX (Recombinant)] to Medexus Pharmaceuticals (MDP:CA) for estimated proceeds in excess of $100 million, including potential milestone and deferred payments.

Under the terms of the sale, Medexus acquired the worldwide commercial rights to IXINITY, previously marketed by Aptevo in the United States for use in people 12 years of age or older with hemophilia B. Total proceeds, estimated to exceed $100 million, include an upfront payment of $30 million as well as potential milestone payments totaling up to $11 million related to certain regulatory and commercial achievements. In addition, for up to fifteen years, Aptevo will receive deferred payments on future U.S. and Canadian net sales of IXINITY. These deferred payments are estimated to exceed $60 million based on the most recent Aptevo forecast and will vary based on actual results.

"Our divestiture of IXINITY represents a transformative event for Aptevo," said Marvin L. White, President and Chief Executive Officer. "Firstly, the significant non-dilutive funding provided by this transaction immediately strengthens Aptevo's financial position. Our cash runway will support our organization into the fourth quarter, through potential upcoming valuation catalysts in 2020. We are today repaying our $20 million debt obligation to MidCap Financial, and, as a result will also eliminate the restriction on $5 million of our cash balance. Secondly, and most importantly, this divestiture transforms Aptevo into a ‘pure play' biotechnology company sharpening our focus on our promising core technology – our ADAPTIR bispecific platform, a proprietary approach focused on developing novel antibody-based immunotherapies which hold significant promise for the treatment of cancer and other diseases. Going forward, as we execute on a ‘pure-play' biotech strategy we will continue to prioritize non-dilutive funding opportunities for future capital requirements for the organization."

Recent advances showcased by leading pharmaceutical companies at the latest American Society of Hematology annual meeting demonstrate that bispecific antibody therapies are quickly becoming established as the next wave of promising cancer immunotherapies. Compelling proof-of-concept clinical data were presented that support the potential for bispecific therapies to offer an efficacious but simpler alternative to other T cell-based immunotherapy approaches for cancer treatment.

Aptevo believes that its differentiated ADAPTIR bispecific technology platform has the potential to offer a more convenient and cost-effective solution compared to other immunotherapies such as CAR-T therapies. While these therapies have proven effective in generating robust and durable treatment responses, they remain challenging and expensive to manufacture and administer to patients. In contrast, Aptevo believes that bispecific technologies represent a simpler, more competitive ‘off-the-shelf' solution in the rapidly advancing field of cancer immunotherapy.

"As bispecifics continue to make tremendous strides forward, we are very enthusiastic about the potential of our ADAPTIR platform and our individual bispecific candidates," said Mr. White. "Importantly, our lead candidate, APVO436, which we are investigating for the treatment of acute myeloid leukemia (AML) is poised to make significant progress this year as we are now dosing at levels which the pharmacokinetic data suggest could be biologically active, and so this is a very exciting year for the ADAPTIR program. Also, recently the Leukemia & Lymphoma Society selected APVO436 for inclusion in their national Beat AML® Master Clinical Trial, giving us exposure and recognition among leading national cancer research centers and clinicians."

"We are also excited about the potential for our 4-1BB x 5T4 bispecific antibody candidate, ALG.APV-527, partnered with Alligator Bioscience, which we are focused on partnering for advancement into Phase 1 clinical development. Also, in late 2019 we introduced our newest investigational ADAPTIR candidate, APVO603, featuring a novel mechanism of action designed to amplify the adaptive immune response to cancer and which could have utility in the treatment of a variety of solid tumors. We are very excited about each of these molecules and the potential for our ADAPTIR technology to generate multiple novel bispecific compounds with unique mechanisms of action to engage and augment the immune response."

"With a stronger balance sheet and potential future milestone and deferred payments from IXINITY; a promising and productive technology engine – our ADAPTIR platform, and a streamlined focus, Aptevo is well-positioned to advance its core assets towards value-creating milestones and opportunities as we look forward to realizing the full potential of this robust platform," concluded Mr. White.

Piper Sandler acted as exclusive financial advisor to Aptevo for this transaction. Cooley acted as legal advisor to Aptevo for this transaction.

About Hemophilia B

Hemophilia B is a congenital bleeding disorder caused by a deficiency of coagulation factor IX. It affects approximately 1:25,000 male births, with approximately 4,000 persons affected in the U.S. The clinical spectrum may include spontaneous or trauma-induced bleeding into joints, muscles, and soft tissues, resulting in joint damage, reduction in mobility, and severe arthritis, all of which negatively impact health-related quality of life. The primary aim of care is to prevent and treat bleeding by replacing the deficient clotting factor.

About IXINITY

IXINITY is indicated for the control and prevention of bleeding episodes and for perioperative management for adults and children ≥12 years of age with hemophilia B. IXINITY is not indicated for induction of immune tolerance in patients with hemophilia B. IXINITY contains recombinant coagulation factor IX (trenonacog alfa). Trenonacog alfa is a purified single chain glycoprotein derived from Chinese hamster ovary (CHO) cells and has an amino acid sequence that is comparable to the Thr148 allelic form of plasma-derived factor IX. No human or animal proteins are added during any stage of manufacturing or formulation of IXINITY. The recombinant factor IX is purified by a chromatography purification process. The process includes three validated steps for virus inactivation and removal. The process also includes a validated manufacturing step to reduce the presence of CHO proteins in the final drug product.

Indications and Important Risk Information

IXINITY [Coagulation Factor IX (Recombinant)] Lyophilized Powder for Solution for Intravenous Injection is a coagulation factor IX (recombinant) indicated in adults and children ≥ 12 years of age with hemophilia B for control and prevention of bleeding episodes, and for perioperative management. IXINITY is not indicated for induction of immune tolerance in patients with hemophilia B. IXINITY is contraindicated in patients who have known hypersensitivity to IXINITY or its excipients, including hamster protein.

Hypersensitivity reactions, including anaphylaxis, may occur following IXINITY administration. Discontinue use of IXINITY if hypersensitivity symptoms occur and initiate appropriate treatment. Regularly evaluate patients for the development of factor IX inhibitors by appropriate clinical observations and laboratory tests. If expected factor IX activity plasma levels are not attained, or, if bleeding is not controlled as expected with a certain dose, perform an assay that measures factor IX inhibitor concentration. An association between the occurrence of a factor IX inhibitor and allergic reactions has been reported. Individuals with factor IX inhibitors may be at increased risk of severe hypersensitivity reactions or anaphylaxis if re-challenged.

Nephrotic syndrome may occur with IXINITY. Nephrotic syndrome has been reported following attempted immune tolerance induction in hemophilia B patients with factor IX inhibitors and a history of allergic reactions. Thromboembolism may occur when using IXINITY (e.g., pulmonary embolism, venous thrombosis, and arterial thrombosis). Patients may develop hypersensitivity to hamster (CHO) protein as IXINITY contains trace amounts. The most common adverse drug reaction observed in >2% of patients in clinical trials was headache.

Please see full Prescribing Information at www.IXINITY.com.

About Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The Company's lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603 were developed based on the Company's versatile and robust ADAPTIR™ modular protein technology platform. The ADAPTIR platform is capable of generating highly differentiated bispecific antibodies with unique mechanisms of action for the treatment of different types of cancer. For more information, please visit www.aptevotherapeutics.com

Safe Harbor Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including, without limitation, statements regarding potential milestone payments, Aptevo's outlook, financial performance or financial condition, Aptevo's technology and related pipeline, collaboration and partnership opportunities, commercial portfolio, milestones, and any other statements containing the words "believes," "expects," "anticipates," "intends," "plans," "forecasts," "estimates," "will" and similar expressions are forward-looking statements. These forward-looking statements are based on Aptevo's current intentions, beliefs and expectations regarding future events. Aptevo cannot guarantee that any forward-looking statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from Aptevo's expectations. Investors are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, Aptevo does not undertake to update any forward-looking statement to reflect new information, events or circumstances.

There are a number of important factors that could cause Aptevo's actual results to differ materially from those indicated by such forward-looking statements, including a deterioration in Aptevo's business or prospects; adverse developments in research and development; adverse developments in the U.S. or global capital markets, credit markets or economies generally; and changes in regulatory, social and political conditions. Additional risks and factors that may affect results are set forth in Aptevo's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K, as filed on March 18, 2019 and its subsequent reports on Form 10-Q and current reports on Form 8-K. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from Aptevo's expectations in any forward-looking statement.

CONTACT:

Aptevo Therapeutics
Stacey Jurchison
Senior Director, Investor Relations and Corporate Communications
206-859-6628
JurchisonS@apvo.com

SOURCE: Aptevo Therapeutics

ReleaseID: 578323

SAN FRANCISCO, CA / ACCESSWIRE / February 28, 2020 / The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation on behalf of investors who purchased shares of the common stock of Six Flags Entertainment Corporation ("Six Flags" or the "Company") (NYSE:SIX) between April 25, 2018 and January 9, 2020, inclusive (the "Class Period").

If you purchased shares of the common stock of Six Flags during the Class Period, you may move the Court for appointment as lead plaintiff by no later than April 13, 2020. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the actions will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.

Six Flags investors who wish to learn more about the litigation and how to seek appointment as lead plaintiff should click here or contact Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358.

Six Flags, incorporated in Delaware and headquartered in Grand Prairie, Texas, is the largest regional theme park operator in the world, with 26 parks across North America.

The complaint alleges that throughout the Class Period, defendants made false and misleading statements to investors regarding the Company's business, operations, and growth prospects in connection with its agreements with Riverside Investment Group Co. Ltd. ("Riverside"), a real estate developer, to develop Six Flags-branded theme parks in China. Further, defendants misled investors by assuring that delays in developing the parks were "short term," that the problems were "not material in the context of long-term opportunity," and that Riverside was in "great shape" financially.

The truth about defendants' fraud began to emerge on February 14, 2019, when Six Flags announced a negative $15 million revenue adjustment for fourth quarter of 2018 as a result of delays in the opening of multiple parks in China, which the Company falsely attributed to macroeconomic issues in China. On this news, the Company's stock price fell $9.00 per share, or over 14%, from its closing price on February 13, 2019 to close at $54.87 per share on February 14, 2019, on unusually heavy trading volume.

On October 23, 2019, the Company again announced delays in its park openings in China. In addition, Six Flags reported a 26% drop in international agreements, sponsorship and accommodations revenue for the third quarter of 2019 compared to the third quarter of 2018. On these disclosures, Six Flags's stock price fell $6.35 per share, or 12.4%, from its closing price on October 22, 2019 to close at $44.88 per share on October 23, 2019.

On January 10, 2020, Six Flags revealed that it continued to encounter challenges in the development of its parks in China, that Riverside had defaulted on its payment obligations to Six Flags, and that the Company would realize no revenue from its agreements with Riverside in the fourth quarter 2019 and expected a negative $1 million revenue adjustment in connection with those agreements. Six Flags also disclosed approximately $10 million in charges related to Riverside's default. On this news, Six Flags's stock price fell $7.80 per share, or approximately 17.8%, from its closing price of $43.76 on January 10, 2020 to close at $35.96 per share the next day, January 11, 2020.

About Lieff Cabraser

Lieff Cabraser Heimann & Bernstein, LLP, with offices in San Francisco, New York, and Nashville, is a nationally recognized law firm committed to advancing the rights of investors and promoting corporate responsibility.

The National Law Journal has recognized Lieff Cabraser as one of the nation's top plaintiffs' law firms for fourteen years. In compiling the list, the National Law Journal examines recent verdicts and settlements and looked for firms "representing the best qualities of the plaintiffs' bar and that demonstrated unusual dedication and creativity." Law360 has selected Lieff Cabraser as one of the Top 50 law firms nationwide for litigation, highlighting our firm's "laser focus" and noting that our firm routinely finds itself "facing off against some of the largest and strongest defense law firms in the world." Benchmark Litigation has named Lieff Cabraser one of the "Top 10 Plaintiffs' Firms in America."

For more information about Lieff Cabraser and the firm's representation of investors, please visit https://www.lieffcabraser.com/.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Source/Contact for Media Inquiries Only

Sharon M. Lee
Lieff Cabraser Heimann & Bernstein, LLP
Telephone: 1-800-541-7358

SOURCE: Lieff Cabraser Heimann & Bernstein, LLP

ReleaseID: 578261

VANCOUVER, BC / ACCESSWIRE / February 28, 2020 / GREAT ATLANTIC RESOURCES CORP. (TSXV:GR) (the "Company" or "Great Atlantic") is pleased to announce it is preparing and planning to submit an application for Phase 2 diamond drilling at its Golden Promise Gold Property, located within the central Newfoundland gold belt. The drilling is planned for 2020 at the Jaclyn Zone, specifically the Jaclyn Main Zone (JMZ) and along projected strike east of the Jaclyn North Zone (JNZ). The JMZ and JNZ host gold bearing quartz vein systems. Planned drilling east of the JNZ will test an area of high-grade quartz boulders.

Quartz Vein Boulder with Visible Gold from 2017 Trench 4
(2.9 Kilogram Grab Sample Returned 332.67 g/t Au)

The Jaclyn Zone is located within the northern region of the Golden Promise Property and hosts five gold bearing quartz veins systems, being the JMZ, JNZ, Jaclyn South Zone, Jaclyn East Zone and Jaclyn West Zone.

The Phase 2 drilling application will include a series of drill holes east of and along projected strike of the JNZ including areas of high-grade quartz boulders. The JNZ is located approximately 250 meters north of the JMZ. During 2017 Great Atlantic excavated high-grade quartz boulders in trenches east of and along projected strike of the JNZ. Assays of quartz boulder samples excavated during 2017 east of the JNZ included 163.99, 208.51 and 332.67 g/t gold (Great Atlantic News Release of August 31, 2017).

All rock samples collected during the 2017 trenching program were submitted to Eastern Analytical (Springdale, Newfoundland) for preparation and analysis. The high-grade quartz vein boulder samples were analyzed for gold by Total Pulp Metallics – Fire Assay. The sample submission included gold standard and blank samples.

The Phase 2 drilling application will include in-fill drill holes at the JMZ. This will include additional drill holes in the west area of the JMZ within the conceptual open pit area. This area of the JMZ was the focus of the Company's 2019 Phase 1 drilling program which consisted of 10 holes totalling 1,063M. Drill core samples from seven holes exceeded 10 grams per tonne (g/t) gold (Company News Releases of February 6, 12 and 19, 2020).

Highlights of near surface gold intersections from the 2019 program include (core length):

GP19-137: 12.37 grams per tonne (g/t) gold over 1.90 meters
GP19-138: 113.07 g/t gold over 0.55 meters.
GP19-139: 15.80 g/t gold over 2.70 meters.
GP19-140: 2.30 g/t gold over 25.25 meters (includes 5 gold bearing veins)
GP19-144: 61.35 g/t gold over 2.04 meters.
GP19-145: 14.49 g/t gold over 1.52 meters.

The drill core samples from the 2019 program were analyzed at Eastern Analytical Ltd. Samples of main quartz veins and quartz veined zones were analyzed by the Total Pulp Metallics method. This involves crushing of the entire sample to -10 mesh and pulverizing to 95% -150 mesh. The total sample is then weighed and screened 150 mesh. The +150 mesh fraction is fire assayed for gold, and a 30 gram sub-sample of the -150 mesh fraction is fire assayed for gold. A calculated weighted average of total gold in the sample is reported as well (gold values reported by the Company in News Releases are weighted average values). Other samples were assayed for gold by fire assay (30-gram sub-samples) and analyzed for 34 elements (200-mg sub-samples totally dissolved in four acids and analyzed by ICP-OES). Eastern Analytical, a certified laboratory, is independent of Great Atlantic. Blank and standard samples were included with the drill core sample submissions to Eastern Analytical. Duplicate analysis was conducted for some samples.

Great Atlantic reported a National Instrument 43-101 mineral resource estimate for the JMZ in late 2018 (News Release of December 6, 2018; and Sedar-filed National Instrument 43-101 Technical Report on the Golden Promise Property, Central Newfoundland (revised), dated December 4, 2018 by Mr. Greg Z. Mosher, M.Sc. App., P.Geo., and Mr. Larry Pilgrim, B.Sc., P.Geo.). The reported inferred mineral resource estimate for the JMZ is as follows:

Resource

Cutoff Au g/t

Au Cap g/t

Au Uncap g/t

Tonnes

Au Ounces Capped

Au Ounces Uncapped

Total

1.1

9.3

10.4

357,500

106,400

119,900

Pit-Constrained

0.6

11.4

14.1

157,300

57,800

71,200

Underground

1.5

7.5

7.6

200,200

48,600

48,700

Mineral Resources are not Mineral Reserves and do not have demonstrated economic viability.

There is no certainty that all or any part of the Mineral Resources estimated will be converted into Mineral Reserves.

Mineral resource tonnage and contained metal have been rounded to reflect the accuracy of the estimate, and numbers may not add due to rounding.

Mineral resource tonnage and grades are reported as undiluted.

Contained Au ounces are in-situ and do not include recovery losses

As reported in the National Instrument 43-101 Technical Report on the Golden Promise Property, Central Newfoundland (revised), dated December 4, 2018 by Mr. Greg Z. Mosher, M.Sc. App., P.Geo., and Mr. Larry Pilgrim, B.Sc., P.Geo., the JMZ was modelled as a single quartz vein that strikes east-west and dips steeply to the south. Modelled vein thickness was based on true thickness derived from quartz vein intercepts. The estimate is based on 220 assays that were composited to 135 one-meter long composites. A bulk density of 2.7 g/cm3 was used. Blocks in the model measured 15 meters east-west, 1-meter north-south and 10 meters vertically. The block model was not rotated. Grades were interpolated using inverse-distance squared (ID2) weighting and a search ellipse that measured 100 meters along strike, two meters across strike and 50 meters vertically. Grades were interpolated based on a minimum of two and a maximum of 10 composites with a maximum of one composite per hole so the grade of each block is based on at least two drill holes thereby demonstrating continuity of mineralization. For the capped mineral resource estimate, all assays that exceed 65 g/t gold were capped at 65 g/t gold. All resources were classified as Inferred because of the relatively wide spacing of drill holes through most of the zone.

Because part of the vein is near surface the resource estimate was constrained by a conceptual open pit to demonstrate reasonable prospects of eventual economic extraction. Generic mining costs of US$2.50/tonne and processing costs of US$25.00/tonne were used together with a gold price of US$1,300/ounce. A conceptual pit slope of 45° was assumed with no allowance for mining loss or dilution. Based on the combined hypothetical mining and processing costs and the assumed price of gold, a pit-constrained cutoff grade of 0.6 g/t was adopted. For the underground portion of the resource a cutoff of 1.5 g/t was assumed. The cutoff grade for the total resource is the weighted average of the pit-constrained and underground cutoff grades.

The Golden Promise Property hosts multiple gold bearing quartz veins and is located within a region of recent significant gold discoveries. The property is located within the Exploits Subzone of the Newfoundland Dunnage Zone. Within the Exploits Subzone, the property lies along the north-northwestern fringe of the Victoria Lake Supergroup (VLSG), a volcano-sedimentary terrane. The northwestern margin of the Golden Promise Property occurs proximal to, and, in part, contiguous with a major (Appalachian-scale) collisional boundary, and suture zone, known as the Red Indian Line (RIL). The RIL forms the western boundary of the Exploits Subzone. Recent significant gold discoveries in this region of the Exploits Subzone include those of Sokoman Minerals Corp. (SIC) at the Moosehead Gold Project and Marathon Gold Corp. (MOZ) at the Valentine Gold Project. Readers are warned that mineralization at the Moosehead Property and Valentine Gold Project is not necessarily indicative of mineralization on the Golden Promise Property.

David Martin, P.Geo., a Qualified Person as defined by NI 43-101 and VP Exploration for Great Atlantic, is responsible for the technical information contained in this News Release.

On Behalf of the Board of Directors

"Christopher R Anderson"

Mr. Christopher R. Anderson "Always be positive, strive for solutions, and never give up"
President CEO Director
604-488-3900 – Dir

Investor Relations:
Please call 604-488-3900

About Great Atlantic Resources Corp.: Great Atlantic Resources Corp. is a Canadian exploration company focused on the discovery and development of mineral assets in the resource-rich and sovereign risk-free realm of Atlantic Canada, one of the number one mining regions of the world. Great Atlantic is currently surging forward building the company utilizing a Project Generation model, with a special focus on the most critical elements on the planet that are prominent in Atlantic Canada, Antimony, Tungsten and Gold.

This press release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address future exploration drilling, exploration activities and events or developments that the Company expects, are forward looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include exploitation and exploration successes, continued availability of financing, and general economic, market or business conditions.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Great Atlantic Resource Corp.

ReleaseID: 578294

DALLAS, TX / ACCESSWIRE / February 28, 2020 / Envela Corporation (NYSE American:ELA) ("Envela" or the "Company") announced today that it is excited about its subsidiary's investment into the future development of CExchange.

As consumers are becoming more aware of how used devices affect the environment, they understand why it's important to extent their useful life and or properly recycle them. The combined services that ECHG and CExchange will be able to offer to the consumer electronics marketplace every aspect from forward logistics to end of life services to maximize their customers returns on their electronic assets.

CExchange is the leader in retail trade-in services, providing in-store and online solutions for most of the major consumer electronics retailers in the United States. CExchange helps retailers provide in-store trade in programs designed to allow customers to turn their old technology into new money at their retail stores in just a couple of minutes. Someone intending to sell his or her old phone or tablet can maximize the value for their used electronics and protect the environment, by either visiting one of its retail partner's stores, including Walmart, Target, Costco and Sam's Club, or sell it through an online portal exclusively powered by CExchange.

CExchange helps its partners gain and retain customers and deliver an exceptional customer experience by consistently beating offer prices of top competitors for device trade-ins. Using direct-to-consumer sales in addition to wholesale partners, CExchange is able to move devices quickly and sell them for the highest price, regardless of age or type. In addition, CExchange provides forward and reverse logistics, refurbish and repair, returns and overstock liquidation and compliance management.

ECHG's expertise includes retail stores, e-commerce, de-manufacturing, recycling, IT asset disposition (ITAD), and reverse logistics. Together ECHG and CExchange can now provide their customers with the best in class recommerce services to maximize their customers returns on their electronics investments – from trade-in, to returns management, to asset recovery, to end of life recycling.

"Combining CExchange into ECHG's family of companies is the logical next step for both companies," said Hunter Howard, Co-founder of CExchange. "We get to serve the most remarkable group of clients and this combination with ECHG is a singular opportunity to significantly diversify our service offering to our customer base enabling us to accelerate our growth and enhance our financial flexibility. So strategically this gets us excited to think about how we can be a more significant and relevant for our clients," added Howard.

About CExchange

CExchange is a leading electronics trade-in and recycling service for retailers. It provides custom solutions to meet the needs of diverse clients, including Fortune 500 companies, both online and offline. CExchange is committed to providing services that help consumers get maximum value for their used electronics and protect the environment through responsible recycling. Its services include reverse logistics and refurbishing; and resale and liquidation services for returned, excess, and other liquidated merchandise. Since servicing its first Fortune 500 company in 2007, CExchange has sold hundreds of millions of dollars of inventory.

About Envela

Envela and its subsidiaries engage in diverse business activities within the recommerce sector. These include one of the nation's premier authenticated recommerce retailers of luxury hard assets; end-of-life asset recycling; data destruction and IT asset management; and providers of products, services and solutions to industrial and commercial companies.

Envela operates primarily via two business segments. Through DGSE, LLC, the Company will operate its Dallas Gold and Silver Exchange, Charleston Gold & Diamond Exchange, and Bullion Express brands. Under ECHG, LLC, it will operate Echo Environmental, ITAD USA and Teladvance. Envela is a Nevada corporation, headquartered in Dallas, Texas.

Additional information about Envela is available at its investor-relations site, Envela.com.

Forward-Looking Statements

This press release includes statements that may constitute "forward-looking" statements, including statements regarding future equity acquisitions, business strategies, and the potential future success of CExchange. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, market conditions and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release except as required by law.

Investor Relations Contact:
David Vadala
Head of Investor Relations
Envela Corporation
13022 Preston Rd Dallas, TX 75240
972.587.4030

SOURCE: Envela Corporation

ReleaseID: 578314

RONKONKOMA, NY / ACCESSWIRE / February 28, 2020 / Lakeland Industries, Inc. (NASDAQ:LAKE) (the "Company" or "Lakeland"), a leading global manufacturer of protective clothing for industry, healthcare and to first responders on the federal, state and local levels, today announced that it will be presenting in the third annual LD Micro Virtual Conference on Wednesday, March 4, at 12:00 PM PST/3:00 PM EST. Lakeland management will be giving the presentation and answering questions from investors.

The conference will be held via webcast and will feature over 40 companies in the small/micro-cap space. The investor presentation used by Lakeland Industries at the conference will be posted in the investor relations section of the Company's website on the day of the event.

Interested parties can register in advance or access the live presentation at the following link: https://www.webcaster4.com/Webcast/Page/2019/33425

View the profile for Lakeland Industries here: http://www.ldmicro.com/profile/lake

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

About Lakeland Industries, Inc.:

We manufacture and sell a comprehensive line of industrial protective clothing and accessories for the industrial and public protective clothing market. Our products are sold globally by our in-house sales teams, our customer service group, and authorized independent sales representatives to a network of over 1,600 global safety and industrial supply distributors. Our authorized distributors supply end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories and the utilities industry. In addition, we supply federal, state and local governmental agencies and departments, such as fire and law enforcement, airport crash rescue units, the Department of Defense, the Department of Homeland Security and the Centers for Disease Control. Internationally, we sell to a mixture of end users directly, and to industrial distributors depending on the particular country and market. Sales are made to more than 50 countries, the majority of which were into the United States, China, the European Economic Community ("EEC"), Canada, Chile, Argentina, Russia, Kazakhstan, Colombia, Mexico, Ecuador, India, Uruguay and Southeast Asia.

For more information concerning Lakeland, please visit the Company online at www.lakeland.com.

Contacts:

Lakeland Industries, Inc. Darrow Associates

256-350-3873 512-551-9296

Allen Dillard, CFO Jordan Darrow

aedillard@lakeland.com jdarrow@darrowir.com

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Forward-looking statements involve risks, uncertainties and assumptions as described from time to time in Press Releases and Forms 8-K, registration statements, quarterly and annual reports and other reports and filings filed with the Securities and Exchange Commission or made by management. All statements, other than statements of historical facts, which address Lakeland's expectations of sources or uses for capital or which express the Company's expectation for the future with respect to financial performance or operating strategies can be identified as forward-looking statements. As a result, there can be no assurance that Lakeland's future results will not be materially different from those described herein as "believed," "projected," "planned," "intended," "anticipated," "estimated" or "expected," or other words which reflect the current view of the Company with respect to future events. We caution readers that these forward-looking statements speak only as of the date hereof. The Company hereby expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in the Company's expectations or any change in events conditions or circumstances on which such statement is based.

Profiles powered by LD Micro – News Compliments of Accesswire

SOURCE: Lakeland Industries, Inc. via LD Micro

ReleaseID: 578316

HOUSTON, TX / ACCESSWIRE / February 28, 2020 / Cub Energy Inc. ("Cub" or the "Company") (TSXV:KUB), a Ukraine-focused upstream oil and gas company, announces that KUB-Gas LLC ("Kub-Gas"), Cub's 35%-owned subsidiary which owns and operates the eastern Ukraine licences, has drilled the Makeevskoye-30 ("M-30") well to a total depth of 1,985 metres. Logging was performed on several horizons and was evaluated as having non-commercial gas shows. The well will be abandoned and Kub-Gas is reviewing its options for its next operation.

About Cub Energy Inc.

Cub Energy Inc. (TSX-V: KUB) is an upstream oil and gas company, with a proven track record of exploration and production cost efficiency in Ukraine. The Company's strategy is to implement western technology and capital, combined with local expertise and ownership, to increase value in its undeveloped land base, creating and further building a portfolio of producing oil and gas assets within a high pricing environment.

For further information please contact us or visit our website: www.cubenergyinc.com

Mikhail Afendikov
Chairman and Chief Executive Officer
(713) 677-0439
mikhail.afendikov@cubenergyinc.com

Patrick McGrath
Chief Financial Officer
(713) 577-1948
patrick.mcgrath@cubenergyinc.com

The disclosure in this press release is prepared in accordance with NI 51-101 standards.

Reader Advisory

Except for statements of historical fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Cub believes that the expectations reflected in the forward-looking information are reasonable; however there can be no assurance those expectations will prove to be correct. We cannot guarantee future results, performance or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information.

Forward-looking information is based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: general economic conditions in Ukraine, the Black Sea Region and globally; political unrest and security concerns in Ukraine; industry conditions, including fluctuations in the prices of natural gas and foreign currency; governmental regulation of the natural gas industry, including environmental regulation; unanticipated operating events or performance which can reduce production or cause production to be shut in or delayed; failure to obtain industry partner and other fourth party consents and approvals, if and when required; competition for and/or inability to retain drilling rigs and other services; the availability of capital on acceptable terms; the need to obtain required approvals from regulatory authorities; stock market volatility; volatility in market prices for natural gas; liabilities inherent in natural gas operations; competition for, among other things, capital, acquisitions of reserves, undeveloped lands, skilled personnel and supplies; incorrect assessments of the value of acquisitions; geological, technical, drilling, processing and transportation problems; changes in tax laws and incentive programs relating to the natural gas industry; failure to realize the anticipated benefits of acquisitions and dispositions; and the other factors. Readers are cautioned that this list of risk factors should not be construed as exhaustive.

This cautionary statement expressly qualifies the forward-looking information contained in this news release. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Cub Energy Inc.

ReleaseID: 578341